JPET xPharm- The Comprehensive Pharmacology Reference

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Parfenova, H.
Right arrow Articles by Leffler, C. W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Parfenova, H.
Right arrow Articles by Leffler, C. W.

Dilator prostanoid-induced cyclic AMP formation and release by cerebral microvascular smooth muscle cells: inhibition by indomethacin

H Parfenova, P Hsu and CW Leffler

Department of Physiology/Biophysics, University of Tennessee, Memphis.

The effect of indomethacin on dilator prostanoid receptor-mediated cAMP formation was investigated using primary cultures of vascular smooth muscle cells from the newborn pig cerebral microvessels. Cerebral microvascular smooth muscle cells responded to dilator prostanoids (iloprost > PGE2) by increasing cAMP formation and release into the media (EC50 = 2 x 10(-8) M and 2 x 10(-7) M for iloprost and PGE2, respectively). Indomethacin inhibited iloprost- and PGE2-evoked increases in cAMP formation (IC50 = 10(-4) M) and release (IC50 = 10(- 6) M) by microvascular smooth muscle cells (maximal inhibition 80-90%), whereas isoproterenol-induced cAMP formation was only slightly attenuated at the highest concentration of indomethacin used (10(-3) M). Aspirin was much less effective in inhibiting dilator prostanoid- induced cAMP formation and release by the cells. Direct analysis of prostacyclin receptor sites using [3H]iloprost as the ligand revealed saturable, high affinity (ED50 = 2 x 10(-8) M) and reversible binding to the membranes isolated from cerebrovascular smooth muscle cells. Indomethacin dose-dependently inhibited [3H]iloprost receptor binding (ID50 = 10(-4) M; maximal inhibition, 70%). The present data suggest that combination of highly effective inhibition of prostaglandin H synthase and receptor binding resulting in inhibition of dilator prostanoid-mediated cAMP formation in target cells may contribute to the increased efficacy of indomethacin compared with other prostaglandin H synthase inhibitors in blocking certain vasodilator responses associated with prostanoids.

Volume 272, Issue 1, pp. 44-52, 01/01/1995
Copyright © 1995 by American Society for Pharmacology and Experimental Therapeutics




This article has been cited by other articles:


Home page
J. Pharmacol. Exp. Ther.Home page
K. Nakae, K. Saito, T. Iino, N. Yamamoto, M. Wakabayashi, S. Yoshikawa, S. Matsushima, H. Miyashita, H. Sugimoto, A. Kiba, et al.
A Prostacyclin Receptor Antagonist Inhibits the Sensitized Release of Substance P from Rat Sensory Neurons
J. Pharmacol. Exp. Ther., December 1, 2005; 315(3): 1136 - 1142.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
A. O. Oyekan
Contributions of Nitric Oxide and Prostanoids and Their Signaling Pathways to the Renal Medullary Vasodilator Effect of U46619 (9-11-Dideoxy-11{alpha},9a-Epoxymethano-Prostaglandin F2a) in the Rat
J. Pharmacol. Exp. Ther., February 1, 2003; 304(2): 507 - 512.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
A. P. Willis and C. W. Leffler
Endothelial NO and prostanoid involvement in newborn and juvenile pig pial arteriolar vasomotor responses
Am J Physiol Heart Circ Physiol, December 1, 2001; 281(6): H2366 - H2377.
[Abstract] [Full Text] [PDF]


Home page
Exp. Biol. Med.Home page
P. A. Parkinson, H. Parfenova, and C. W. Leffler
Phospholipase C Activation by Prostacyclin Receptor Agonist in Cerebral Microvascular Smooth Muscle Cells
Experimental Biology and Medicine, January 1, 2000; 223(1): 53 - 58.
[Abstract] [Full Text]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
C. W. Leffler, L. Balabanova, and K. K. Williams
cAMP production by piglet cerebral vascular smooth muscle cells: pHo, pHi, and permissive action of PGI2
Am J Physiol Heart Circ Physiol, November 1, 1999; 277(5): H1878 - H1883.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
B. Zucker and C. W. Leffler
PTX-sensitive G proteins and permissive action of prostacyclin in newborn pig cerebral circulation
Am J Physiol Heart Circ Physiol, July 1, 1998; 275(1): H259 - H263.
[Abstract] [Full Text] [PDF]


Home page
Physiol. Rev.Home page
F. M. FARACI and D. D. HEISTAD
Regulation of the Cerebral Circulation: Role of Endothelium and Potassium Channels
Physiol Rev, January 1, 1998; 78(1): 53 - 97.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
F. Bari, T. M. Louis, W. Meng, D. W. Busija, and W. G. Mayhan
Global Ischemia Impairs ATP-Sensitive K+ Channel Function in Cerebral Arterioles in Piglets
Stroke, October 1, 1996; 27(10): 1874 - 1881.
[Abstract] [Full Text]


Home page
StrokeHome page
C. W. Leffler, A. L. Fedinec, and M. Shibata
Prostacyclin Receptor Activation and Pial Arteriolar Dilation After Endothelial Injury in Piglets
Stroke, November 1, 1995; 26(11): 2103 - 2111.
[Abstract] [Full Text]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1995 by the American Society for Pharmacology and Experimental Therapeutics.